| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8770426 | The Journal of Urology | 2018 | 31 Pages |
Abstract
SER120 demonstrated significant improvements over placebo for co-primary and secondary efficacy end points that corresponded with quality of life improvements. SER120 at each dose had an acceptable safety profile.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jed Kaminetsky, Seymour Fein, Roger Dmochowski, Scott MacDiarmid, Steven Abrams, Maria Cheng, Alan Wein,